Effects of rhythmic auditory stimulation on upper-limb movement speed in patients with schizophrenia spectrum disorders

被引:0
|
作者
Shu-Mei Wang
Chung-Ying Lin
Tracy Ho-Yan Tse
Hin-Lun Chu
Cheong-Ho Liu
Tsz-Ho Ng
Chun-Kwok Tse
Wai-Man Wong
Sunny Ho-Wan Chan
机构
[1] The Hong Kong Polytechnic University,Department of Rehabilitation Sciences
[2] National Cheng Kung University,Institute of Allied Health Sciences, National Cheng Kung University Hospital, College of Medicine
[3] New Life Psychiatric Rehabilitation Association,undefined
来源
European Archives of Psychiatry and Clinical Neuroscience | 2021年 / 271卷
关键词
Rhythmic auditory stimulation; Auditory cue; Upper limb movement; Schizophrenia;
D O I
暂无
中图分类号
学科分类号
摘要
Movement slowness, linked to dysfunctional basal ganglia and cerebellum, is prevalent but lacks effective therapy in patients with schizophrenia spectrum disorders. This study was to examine immediate effects of rhythmic auditory stimulation (RAS) on upper-limb movement speed in patients. Thirty patients and 30 psychiatrically healthy people executed the right-hand task and the both-hand task of the Purdue Pegboard Test when listening to RAS with two tempi: normal (equal to the fastest movement tempo for each participant without RAS) and fast (120% of the normal tempo). The testing order of the RAS tempi for each participant was randomized. Patients had lower scores of right-hand and both-hand tasks than did psychiatrically healthy people. Scores of right-hand and both-hand tasks were higher in the fast-RAS condition than the normal-RAS condition in participants. This is the first study to explore the possibility of applying RAS to movement therapy for patients with schizophrenia spectrum disorders. The results demonstrated that faster RAS was effective in inducing faster upper-limb movements in patients and psychiatrically healthy people, suggesting that manipulating RAS may be a feasible therapeutic strategy utilized to regulate movement speed. The RAS may involve alternative neural pathways to modulate movement speed and thus to compensate for impaired function of basal ganglia and cerebellum in patients.
引用
收藏
页码:1445 / 1453
页数:8
相关论文
共 23 条
  • [21] Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
    Strube, Wolfgang
    Aksar, Aslihan
    Bauer, Ingrid
    Barbosa, Susana
    Benros, Michael
    Blankenstein, Christiane
    Campana, Mattia
    Davidovic, Laetitia
    Glaichenhaus, Nicolas
    Falkai, Peter
    Gorlitz, Thomas
    Hansbauer, Maximilian
    Heilig, Daniel
    Khalfallah, Olfa
    Leboyer, Marion
    Martinuzzi, Emanuela
    Mayer, Susanne
    Moussiopoulou, Joanna
    Papazova, Irina
    Peric, Natasa
    Wagner, Elias
    Schneider-Axmann, Thomas
    Simon, Judit
    Hasan, Alkomiet
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (08) : 1039 - 1048
  • [22] Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
    Wolfgang Strube
    Aslihan Aksar
    Ingrid Bauer
    Susana Barbosa
    Michael Benros
    Christiane Blankenstein
    Mattia Campana
    Laetitia Davidovic
    Nicolas Glaichenhaus
    Peter Falkai
    Thomas Görlitz
    Maximilian Hansbauer
    Daniel Heilig
    Olfa Khalfallah
    Marion Leboyer
    Emanuela Martinuzzi
    Susanne Mayer
    Joanna Moussiopoulou
    Irina Papazova
    Natasa Perić
    Elias Wagner
    Thomas Schneider-Axmann
    Judit Simon
    Alkomiet Hasan
    Journal of Neural Transmission, 2023, 130 : 1039 - 1048
  • [23] Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials
    Palermo, Sara
    Giovannelli, Fabio
    Bartoli, Massimo
    Amanzio, Martina
    FRONTIERS IN PHARMACOLOGY, 2019, 10